ALLO
Allogene TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ALLO vs peer average
65/100
ALLO vs. peer average (B vs. C)
Grade spread
A 3 · B 2 · C 2 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CADL is the first available peer comparator.
Loose same-size clinical biotech comparator from the packet; useful mainly for financing sensitivity and event-driven readout volatility rather than as a close operating peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALLO
Allogene Therapeutics
CADL
Candel Therapeutics
Grade
B
A
Momentum
96
93
Value
41
41
Sentiment
77
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CADL
ALLO / CADL
Grade Position
In line
ALLO vs. peer average (B vs. C)
65/100
Momentum
96
ALLOValue
41
ALLOSentiment
77
CADLRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALLO
CADL is the first peer returned for this comparison set.